Atea Pharmaceuticals, Inc. Balance Sheet
AVIR|3 years of annual SEC 10-K data (FY2020-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$667M
FY2022
Cash
$188M
Cash and equivalents
Total Debt
N/A
FY2022
Shareholder Equity
$641M
FY2022
Atea Pharmaceuticals, Inc. had $667M in total assets and $641M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Cash & Equivalents | $188.5M | $850.1M | $21.7M |
| Current Assets | $660.9M | $772.4M | $863.5M |
| PP&E (Net) | $1.7M | $23.0K | $48.0K |
| Total Assets | $666.7M | $772.9M | $863.6M |
| Current Liabilities | $18.5M | $56.9M | $315.8M |
| Shareholders' Equity | $640.6M | -$49.6M | -$36.2M |